loratadinã lek 5mg/5ml
lek pharmaceuticals d.d. - slovenia - loratadinum - susp. orala - 5mg/5ml - antihistaminice de uz sistemic alte antihistaminice de uz sistemic
fibryga 1 g
octapharma pharmazeutika produktionsges m.b.h. - austria - fibrinogen uman - pulb.+solv. pt. sol. inj./perf. - 1g - vitamina k si alte hemostatice fibrinogen
haemocomplettan p 1 g
csl behring gmbh - germania - fibrinogen uman - pulb. pt. sol. inj./perf. - 1g - vitamina k si alte hemostatice fibrinogen
egocin Л.А.
krka, Словения - oxitetraciclină dihidrat - крупного рогатого скота, овец, коз, свиней, iepuri, păsări
nexgard 11mg, comprimate p/u câini 2-4 kg
merial, franța - afoxolan - comprimate masticabile - cîini
nexgard 28mg, comprimate p/u câini 4-10 kg
merial, franța - afoxolan - comprimate masticabile - cîini
vaccin asociat mixohemovirovac
srl vetzooagro - vaccin - iepuri
celexium
bayer ag - granule dispersabile în apă, de culoare bej si albe (wg) - florasulam 105.0 g/kg + metsulfuron metil 82.8 g/kg + tribenuron metil 83.0 g/kg
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - agenți antineoplazici - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
imcivree
rhythm pharmaceuticals netherlands b.v. - setmelanotide - obezitatea - preparate antiobezitate, excl. produse alimentare - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.